A pro-aggregant transgenic C. elegans strain which pan-neuronally expresses a rab-3 promoter-driven, highly amyloidogenic, mutated F3ΔK280 fragment of human tau, was used as an in vivo tauopathy model. Here, MAPT is linked to tauopathy.